Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Matthew Britz, Francesco Caiazza, Aditi Hazra, Neetu Singh


Retrogenix has tapped Matthew Britz to be its North American business development director. Britz will operate out of the UK firm's newly established US office in Cambridge, Mass. He previously served as director of business development at Evory Therapeutics and earlier in his career held scientific and managerial positions at Pfizer, Merck, and Acambis.

Affymetrix has announced the three recipients of its 2014 Tumor Profiling Grant. The grants support translational cancer research. Recipients receive tools to discover and validate at least two different analytes – DNA, RNA, or protein – from 30 tumor samples.

The new recipients and their project titles are:

  • Francesco Caiazza from University College Dublin, for "Discovery and validation of biomarkers of resistance to Cetuximab in metastatic colorectal cancer."
  • Aditi Hazra from Brigham and Women's Hospital for "Discovery and validation of genomic and transcriptomic biomarkers associated with rapid onset of inflammatory breast cancer."
  • Neetu Singh of King George's Medical University, India, for "Genomics and transcriptomics of chronic myeloid leukemia in North Indians."
  • The Scan

    Purnell Choppin Dies

    Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

    Effectiveness May Decline, Data From Israel Suggests

    The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

    To See Future Risk

    Slate looks into the use of polygenic risk scores in embryo screening.

    PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

    In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.